Actos Bladder Cancer Lawsuit
Actos® lawsuit kept in California state court for California man

In January of 2012, Actos lawsuits filed in California state court were centralized before Los Angeles Superiour Court Judge Carl J. West for pretrial proceedings; however, U.S. Federal District Judge William Alsup has issued an order allowing a California man to keep his Actos lawsuit in California state court and out of the consolidated Actos Lawsuits.

Jerry Hill, like many others, is filing a lawsuit against Takeda Pharmaceuticals alleging that their type II diabetes medication causes bladder cancer.  Hill was diagnosed with bladder cancer after taking Actos for four years and argued that Takeda San Diego, a Takeda subsidiary, participated in the testing of Actos during development thus making it reasonably possible to hold the company liable under California state law.

Judge Alsup’s decision will impact a number of other Actos lawsuits filed in California state court. This order supports plaintiffs who argue there is a legitimate reason for keeping their case in California state court though Takeda opposes centralization of the cases in California.

Actos Lawsuits have been filed against Takeda in other state courts including three which took place in Illinois.

Each lawsuit involved in the Actos multidistrict litigation involve similar allegations that the blockbuster drug causes bladder cancer and that Takeda Pharmaceuticals should have reasonably known that with Actos long term use comes an increased risk bladder cancer.

Actos was introduced in June of 1999 and has raised significant profits for Takeda Pharmaceuticals since its release. In 2010, the drug generated $4.3 billion in sales. However, in that same year, the Food and Drug Administration began reviewing the risks associated with Actos and later found that there is a potential risk for developing bladder cancer while taking Actos.

A recall was issued in France and Germany and updated warning labels were issued in the U.S. by the FDA in August of 2011.

Tags: 
Categories: 

About the Contributor


Related Posts